Inozyme Pharma, Inc.
NASDAQ:INZY
5.15 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||||
Current Assets: | ||||||||||||||||||||
Cash & Cash Equivalents
| 15.233 | 20.618 | 34.588 | 46.895 | 40.845 | 49.024 | 32.915 | 44.044 | 62.62 | 31.943 | 23.316 | 27.229 | 26.239 | 16.486 | 28.04 | 59.858 | 50.863 | 55.637 | 31.605 | -43.163 |
Short Term Investments
| 129.29 | 145.535 | 154.001 | 145.547 | 99.402 | 81.906 | 94.951 | 97.408 | 88.86 | 65.83 | 88.485 | 98.054 | 111.225 | 128.6 | 119.657 | 99.644 | 13.004 | 18.903 | 15.527 | 86.326 |
Cash and Short Term Investments
| 144.523 | 166.153 | 188.589 | 192.442 | 140.247 | 130.93 | 127.866 | 141.452 | 151.48 | 97.773 | 111.801 | 125.283 | 137.464 | 145.086 | 147.697 | 159.502 | 63.867 | 74.54 | 47.132 | 43.163 |
Net Receivables
| 0 | 0 | 0.385 | 0 | 0 | 0 | 0.115 | 0.096 | 0.106 | 0.048 | 0.062 | 0.073 | 0.095 | 0.122 | 0.155 | 0.252 | 0.082 | 0.044 | 0.104 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | -0.115 | 0 | -0.106 | 0 | -0.062 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 8.439 | 8.171 | 7.276 | 8.414 | 3.341 | 3.218 | 3.527 | 4.378 | 2.268 | 2.762 | 92.026 | 5.223 | 3.403 | 2.833 | 3.127 | 4.223 | 0.711 | 0.379 | 0.224 | 0 |
Total Current Assets
| 152.962 | 174.324 | 196.25 | 200.856 | 143.588 | 134.148 | 131.393 | 145.926 | 153.748 | 100.583 | 115.342 | 130.579 | 140.962 | 148.041 | 150.979 | 163.977 | 64.66 | 74.963 | 47.46 | 43.163 |
Non-Current Assets: | ||||||||||||||||||||
Property, Plant & Equipment, Net
| 1.981 | 2.308 | 2.592 | 2.84 | 3.169 | 3.484 | 3.638 | 3.931 | 4.052 | 4.184 | 4.436 | 4.743 | 4.859 | 5.029 | 2.648 | 2.455 | 0.846 | 0.374 | 0.298 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.311 | 0.311 | 0.311 | 0.311 | 0.311 | 0.354 | 0.354 | 0.354 | 0.379 | 0.354 | 88.485 | 0.354 | 0.354 | 2.548 | 12.199 | 12.207 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.458 | 0 | 1.694 | 1.695 | 3.861 | 3.81 | 3.81 | 3.81 | 3.81 | 3.81 | -84.722 | 2.07 | 2.084 | 3.297 | 3.537 | 0.354 | 3.005 | 0.399 | 0.186 | -43.163 |
Total Non-Current Assets
| 2.75 | 2.619 | 4.597 | 4.846 | 7.341 | 7.648 | 7.802 | 8.095 | 8.241 | 8.348 | 8.199 | 7.167 | 7.297 | 10.874 | 18.384 | 15.016 | 3.851 | 0.773 | 0.484 | -43.163 |
Total Assets
| 155.712 | 176.943 | 200.847 | 205.702 | 150.929 | 141.796 | 139.195 | 154.021 | 161.989 | 108.931 | 123.541 | 137.746 | 148.259 | 158.915 | 169.363 | 178.993 | 68.511 | 75.736 | 47.944 | 0 |
Liabilities & Equity: | ||||||||||||||||||||
Current Liabilities: | ||||||||||||||||||||
Account Payables
| 3.527 | 2.166 | 1.166 | 2.006 | 2.014 | 1.815 | 2.544 | 1.391 | 1.339 | 2.2 | 2.394 | 0.626 | 0.796 | 1.709 | 3.069 | 3.665 | 1.399 | 1.569 | 0.901 | 0 |
Short Term Debt
| 0.959 | 0.934 | 0.91 | 0.886 | 0.862 | 0.839 | 0.816 | 0.794 | 0.773 | 0.752 | 0.731 | 0.711 | 0.691 | 0.672 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 3.81 | 0 | 3.81 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 11.055 | 9.306 | 12.61 | 9.383 | 9.205 | 9.927 | 7.545 | 10.948 | 4.651 | 9.308 | 8.508 | 7.606 | 5.485 | 4.451 | 6.904 | 6.149 | 5.328 | 3.34 | 2.335 | 0 |
Total Current Liabilities
| 15.541 | 12.406 | 14.686 | 12.275 | 12.081 | 12.581 | 14.715 | 13.133 | 10.573 | 12.26 | 11.633 | 8.943 | 6.972 | 6.832 | 9.973 | 9.814 | 6.727 | 4.909 | 3.236 | 0 |
Non-Current Liabilities: | ||||||||||||||||||||
Long Term Debt
| 45.332 | 45.032 | 44.769 | 33.214 | 33.255 | 25.822 | 5.962 | 6.108 | 2.24 | 2.442 | 2.64 | 2.829 | 3.013 | 3.194 | 1.287 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.419 | 0.669 | 0.913 | 0 | 0 | 0.046 | 0.124 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.263 | 111.803 | 0 | 77.927 | 0 |
Total Non-Current Liabilities
| 45.751 | 45.701 | 45.682 | 33.214 | 33.255 | 25.868 | 6.086 | 6.108 | 2.24 | 2.442 | 2.64 | 2.829 | 3.013 | 3.194 | 1.287 | 1.263 | 111.803 | 0 | 77.927 | 0 |
Total Liabilities
| 61.292 | 58.107 | 60.368 | 45.489 | 45.336 | 38.449 | 20.801 | 19.241 | 12.813 | 14.702 | 14.273 | 11.772 | 9.985 | 10.026 | 11.26 | 11.077 | 118.53 | 4.909 | 81.163 | 0 |
Equity: | ||||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 178.993 | 44.657 | 77.927 | 77.927 | 55.029 |
Common Stock
| 0.006 | 0.006 | 0.006 | 0.006 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0 | 0.001 | 0 | 0 |
Retained Earnings
| -336.31 | -309.277 | -285.93 | -264.386 | -247.748 | -232.165 | -214.761 | -196.217 | -179.845 | -164.584 | -147.7 | -128.946 | -114.666 | -102.126 | -91.076 | -79.958 | -51.863 | -60.149 | -34.652 | 0 |
Accumulated Other Comprehensive Income/Loss
| -0.103 | -0.105 | 0.041 | -0.078 | 0.051 | -0.036 | -0.205 | -0.477 | -0.397 | -0.129 | 0.018 | 0.003 | 0.018 | 0.012 | 0.002 | -178.993 | 0.013 | 0.028 | 0.005 | -13.875 |
Other Total Stockholders Equity
| 430.827 | 428.212 | 426.362 | 424.671 | 353.285 | 335.576 | 333.356 | 331.47 | 329.414 | 258.94 | 256.948 | 254.915 | 252.92 | 251.001 | 249.175 | 247.872 | 1.831 | 53.02 | -76.499 | 0 |
Total Shareholders Equity
| 94.42 | 118.836 | 140.479 | 160.213 | 105.593 | 103.379 | 118.394 | 134.78 | 149.176 | 94.229 | 109.268 | 125.974 | 138.274 | 148.889 | 158.103 | 167.916 | -50.019 | 70.827 | -33.219 | 41.154 |
Total Equity
| 94.42 | 118.836 | 140.479 | 160.213 | 105.593 | 103.379 | 118.394 | 134.78 | 149.176 | 94.229 | 109.268 | 125.974 | 138.274 | 148.889 | 158.103 | 167.916 | -50.019 | 70.827 | -33.219 | 41.154 |
Total Liabilities & Shareholders Equity
| 155.712 | 176.943 | 200.847 | 205.702 | 150.929 | 141.828 | 139.195 | 154.021 | 161.989 | 108.931 | 123.541 | 137.746 | 148.259 | 158.915 | 169.363 | 178.993 | 68.511 | 75.736 | 47.944 | 41.154 |